ARTICLE
2 October 2013

A Primer: Recent Developments And Strategies in Petitions and Lawsuits Challenging FDA Approval Of Generic Drug Products Under The Administrative Procedure Act

W
WilmerHale

Contributor

WilmerHale provides legal representation across a comprehensive range of practice areas critical to the success of its clients. With a staunch commitment to public service, the firm is a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 12 offices in the United States, Europe and Asia.
Partner Bruce Manheim Publishes Chapter on Food and Drug Litigation Strategies.
United States Food, Drugs, Healthcare, Life Sciences

WilmerHale Partner Bruce Manheim authored a chapter in the newly-released book, Inside the Minds: Food and Drug Litigation Strategies. Senior Associate Skye Perryman assisted in the development of this chapter. 

"A Primer: Recent Developments and Strategies in Petitions and Lawsuits Challenging FDA Approval of Generic Drug Products Under the Administrative Procedure Act", addresses high-stakes litigation involving challenges to approval by the US Food and Drug Administration of generic versions of brand-name drug products.  Many of the principles outlined in the chapter will also apply to challenges involving FDA review and approval of biosimilars.

Inside the Minds: Food and Drug Litigation Strategies provides an authoritative, insider's perspective on best practices for "leading lawyers on building strong defenses and adapting to evolving FDA regulations." It is available for purchase through Aspatore Books, a Thomson Reuters business.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More